MAYWOOD, IL – On May 19, leading experts on cancer immunotherapy from around the country gathered for Loyola University Chicago’s 5th Annual Translational Science Symposium.
The symposium was held at Loyola’s new Center for Translational Research and Education, 2160 S. First Ave., Maywood. The meeting was sponsored by Loyola Stritch School of Medicine’s cancer immunotherapeutics program.
Immunotherapy harnesses a patient’s immune system to attack and kill cancer cells. “It’s one of the hottest new areas of cancer therapy, and it’s making a real impact on patients’ lives,” said Michael I. Nishimura PhD, program leader of Loyola’s cancer immunology program and co-director of Loyola’s Oncology Research Institute.
Eight nationally or internationally known speakers, who are leaders in their areas of cancer immunology, spoke. There also was a poster session in which researchers presented their work.
The symposium “represents an excellent opportunity for those interested in cancer immunology and immunotherapy to have relevant scientific interaction with leading experts,” Nishimura said.
Scheduled speakers were:
- Dmitry I. Gabrilovich, MD, PhD, The Wistar Institute
- Pawel Kalinski, MD, PhD, University of Pittsburgh
- Elizabeth Repasky, PhD, Rosewell Park Cancer Institute
- Michel Sadelain, MD, PhD, Memorial Sloan Kettering Cancer Center
- Jeffrey Schlom, PhD, National Cancer Institute
- Tzyy-Choou Wu, MD, MPH, PhD, Johns Hopkins University
- K. Dane Wittrup, PhD, Massachusetts Institute of Technology
- Marcel van den Brink, MD, PhD, Memorial Sloan Kettering Cancer Center